October 8-11, 2019
Manchester Grand Hyatt San Diego, CA, USA 


Your Definitive Antibody Drug Conjugate Networking Experience – About World ADC

In the last 12 months, we’ve seen the approval of Lumoxiti, multiple ADCs receive Breakthrough Therapy Designation status and novel ADCs enter the clinic. This is coupled with innovations in ADC linker, payload and antibody technologies. Yet, as we all know maximizing the clinical therapeutic index of ADCs is a challenge we’re continuing the grapple with. This means more than ever, there is a lot to be shared and digested at World ADC San Diego 2019.

Now in its 10th year, World ADC San Diego is the industry’s most comprehensive antibody drug conjugate conference.  Designed with AbbVie Stemcentrx, Seattle Genetics and ImmunoGen this leading forum will share the latest data, insight and lessons learned enabling you to maximize the clinical therapeutic window of your ADC candidate.

Click here to register your interest in World ADC San Diego 2019

Across 3 days, over 600+ ADC stakeholders from 220 organizations will converge at World ADC to providing you with an unrivalled networking experience.

Join the ADC community to catch up with friends, meet new peers and further progress partnerships.

Click Here to be the first to see the 2019 World ADC San Diego program